According to a study, patients who underwent an intermittent fasting diet intervention achieved complete diabetes remission, which is defined as a HbA1c (average blood sugar) level of less than 6.5% at least one year after stopping diabetes medication.
Approximately half of the people with type 1 or type 2 diabetes experience peripheral neuropathy -- weakness, numbness, and pain, primarily in the hands and feet. The condition occurs when high levels of sugar circulating in the blood damage peripheral nerves. Now, working with mice, Salk In
Researchers from the Regenstrief Institute showed that continuous glucose monitors and other wearable devices present wearability and use issues for patients and their carers when used by older persons with Type 1 or Type 2 diabetes to test and control low blood sugar.
According to the senior study author Wendy L. Bennett, M.D., M.P.H., an associate professor of medicine at Johns Hopkins University School of Medicine in Baltimore, although 'time-restricted eating patterns' - known as intermittent fasting - are popular, rigorously designed studies have not
A new study, published in Nutrients, from the University of Coimbra discovered that caffeine, polyphenols, and other natural compounds contained in coffee may help lower the severity of non-alcoholic fatty liver disease (NAFLD) in overweight adults with type 2 diabetes (T2D).
A significant increase in the risk of dementia and Alzheimer's disease is associated with various cardiometabolic disorders, such as diabetes, heart disease, and stroke. Researchers from the Karolinska Institutet have recently conducted a twin study that raises the possibility that dementia
A new study at Washington University School of Medicine in St. Louis may help explain how excess weight can contribute to diabetes and may provide researchers with a target to help prevent or delay diabetes in some of those at risk.
Researchers have tested an artificial pancreas for use by type 2 diabetes patients. The device, which was powered by an algorithm developed at the University of Cambridge, compared to standard treatment, patients spent twice as much time in the glucose target range and half as much time expe
Machine learning techniques can predict with certainty the likelihood that patients with type 2 diabetes would have poor glycemic control. The length of type 2 diabetes, previous glucose levels, and the patient's use of anti-diabetic medications are the most crucial variables influencing gly
One type of bacteria found in the gut may contribute to the development of Type 2 diabetes, while another may protect from the disease, according to early results from an ongoing, prospective study led by investigators at Cedars-Sinai.
According to researchers, positive results came from a unique cell treatment experiment for adults with diabetes. A novel cell therapy for the treatment of persons with type 2 diabetes who have progressive kidney impairment despite receiving the best medical care.
This fixed-dose combination has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg), Pioglitazone (15 mg) and Metformin (500mg/1000mg) in a sustained release (SR) formulation, according to the company's statement. It offers patients with type 2 diabetes the con